Left atrial mechanical function and global strain in hypertrophic cardiomyopathy

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Kim, Kyung Jin ^a,b   Choi, Hong Mi ^a,b   Yoon, Yeonyee E ^a,c   Kim, Hack Lyoung ^a   Lee, Seung Pyo ^a,b   Kim, Hyung Kwan ^a,b   Kim, Yong Jin ^a,b   Cho, Goo Yeong ^a,c   Zo, Joo Hee ^a   Sohn, Dae Won ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FUNCTION; HEART ATRIUM REMODELING; HEART LEFT ATRIUM DIAMETER; HEART LEFT ATRIUM MECHANICAL FUNCTION; HEART LEFT ATRIUM VOLUME INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; SPECKLE TRACKING ECHOCARDIOGRAPHY; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; CASE CONTROL STUDY; COMPLICATION; ECHOCARDIOGRAPHY; HEART ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84976580746     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157433     Document Type: Article

References (29)

1. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013; 381(9862):242-55. doi: 10.1016/S0140-6736(12)60397-3 PMID: 22874472.
2. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001; 104(21):2517-24. PMID: 11714644.
3. Siontis KC, Geske JB, Ong K, Nishimura RA, Ommen SR, Gersh BJ. Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High-Risk Population. Journal of the American Heart Association. 2014; 3(3):e001002. doi: 10.1161/JAHA.114.001002 PMID: 24965028
4. Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP, et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2002; 39(2):301-7. PMID: 11788223
5. Yang H, Woo A, Monakier D, Jamorski M, Fedwick K, Wigle ED, et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr. 2005; 18 (10):1074-82. doi: 10.1016/j.echo.2005.06.011 PMID: 16198885.
6. Shin M-S, Fukuda S, Song J-M, Tran H, Oryszak S, Thomas JD, et al. Relationship between left atrial and left ventricular function in hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study. Journal of the American Society of Echocardiography. 2006; 19(6):796-801. PMID: 16762759
7. Caselli S, Maron MS, Urbano-Moral JA, Pandian NG, Maron BJ, Pelliccia A. Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. The American journal of cardiology. 2014; 114(9):1383-9. doi: 10.1016/j.amjcard.2014.07.070 PMID: 25217454.
8. Yoon YE, Oh IY, Kim SA, Park KH, Kim SH, Park JH, et al. Echocardiographic Predictors of Progression to Persistent or Permanent Atrial Fibrillation in Patients with Paroxysmal Atrial Fibrillation (E6P Study). J Am Soc Echocardiogr. 2015; 28(6):709-17. doi: 10.1016/j.echo.2015.01.017 PMID: 25704553.
9. Saraiva RM, Demirkol S, Buakhamsri A, Greenberg N, Popović ZB, Thomas JD, et al. Left atrial strain measured by two-dimensional speckle tracking represents a new tool to evaluate left atrial function. Journal of the American Society of Echocardiography. 2010; 23(2):172-80. doi: 10.1016/j.echo.2009. 11.003 PMID: 20152699
10. Yoon YE, Kim HJ, Kim SA, Kim SH, Park JH, Park KH, et al. Left atrial mechanical function and stiffness in patients with paroxysmal atrial fibrillation. Journal of cardiovascular ultrasound. 2012; 20(3):140-5. doi: 10.4250/jcu.2012.20.3.140 PMID: 23185657; PubMed Central PMCID: PMC3498311.
11. Henein M, Zhao Y, Henein MY, Lindqvist P. Disturbed left atrial mechanical function in paroxysmal atrial fibrillation: a speckle tracking study. International journal of cardiology. 2012; 155(3):437-41. doi: 10. 1016/j.ijcard.2011.10.007 PMID: 22088228
12. Hwang HJ, Choi E-Y, Rhee SJ, Joung B, Lee B-H, Lee S-H, et al. Left atrial strain as predictor of successful outcomes in catheter ablation for atrial fibrillation: a two-dimensional myocardial imaging study. Journal of interventional cardiac electrophysiology. 2009; 26(2):127-32. doi: 10.1007/s10840-009- 9410-y PMID: 19529886
13. To AC, Dhillon A, Desai MY. Cardiac magnetic resonance in hypertrophic cardiomyopathy. JACC: Cardiovascular Imaging. 2011; 4(10):1123-37. doi: 10.1016/j.jcmg.2011.06.022 PMID: 21999873
14. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005; 112(6):855-61. PMID: 16087809
15. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014; 130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094 PMID: 25092278
16. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic CardiomyopathyA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2011; 58(25):e212-e60. doi: 10.1016/j.jacc. 2011.06.011 PMID: 22075469
17. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation. 1997; 95(6):1686. PMID: 9118558
18. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. Journal of the American College of Cardiology. 1995; 26 (7):1699-708. PMID: 7594106
19. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2002; 15(2):167-84. PMID: 11836492
20. D'Andrea A, Caso P, Romano S, Scarafile R, Riegler L, Salerno G, et al. Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study. Eur Heart J. 2007; 28(22):2738-48. doi: 10. 1093/eurheartj/ehm443 PMID: 17959621.
21. Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, et al. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology. 2011; 258(1):128-33. doi: 10.1148/radiol.10090526 PMID: 21045187.
22. Maron BJ, Haas TS, Maron MS, Lesser JR, Browning JA, Chan RH, et al. Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance. The American journal of cardiology. 2014; 113(8):1394-400. doi: 10.1016/j. amjcard.2013.12.045 PMID: 24589281.
23. Tigen K, Sunbul M, Karaahmet T, Dundar C, Ozben B, Guler A, et al. Left ventricular and atrial functions in hypertrophic cardiomyopathy patients with very high LVOT gradient: a speckle tracking echocardiographic study. Echocardiography. 2014; 31(7):833-41. doi: 10.1111/echo.12482 PMID: 24341920.
24. Olivotto I, Maron MS, Autore C, Lesser JR, Rega L, Casolo G, et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2008; 52(7):559-66. doi: 10.1016/j.jacc.2008.04.047 PMID: 18687251.
25. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2002; 40(12):2156-64. PMID: 12505229
26. Olivotto I, Maron BJ, Appelbaum E, Harrigan CJ, Salton C, Gibson CM, et al. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. The American journal of cardiology. 2010; 106(2):261-7. doi: 10.1016/j.amjcard.2010.03.020 PMID: 20599013.
27. Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C, et al. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circulation: Heart Failure. 2008; 1 (3):184-91.
28. Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circulation: Heart Failure. 2010; 3(1):51-8.
29. Green JJ, Berger JS, Kramer CM, Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC: Cardiovascular Imaging. 2012; 5(4):370-7. doi: 10.1016/j.jcmg.2011.11.021 PMID: 22498326